GLP-1 Agonist Meds in 2026: Comprehensive Evidence Review of Efficacy, Safety, and Uses By Isaac Introduction GLP-1 agonists, or glucagon-like peptide-1 receptor agonists, represent a cornerstone of modern pharmacotherapy for type 2 diabetes mellitus (T2DM) and obesity management
& Jain, A
Sun H, Li C, Shi Y, Wang Y, Li J, Fan L, Yu Y, Ji X, Gao X, Hou K, Li Y
By improving how efficiently nutrients are absorbed into the body and how full you feel after meals, this medication can help prevent overeating caused by poor digestion or lack of satisfaction from food
There are also newer, broad-spectrum medications that cover all these groups in a single product
Overview of FDA-Approved GLP-1 Agonists Currently, several GLP-1 receptor agonists have received FDA approval, each with unique characteristics